Most Clicked StoriesMore >


Amicus brief filed to urge dismissal of off-label marketing case

FDLI SmartBrief | Aug 27, 2014

An amicus brief filed by the Pharmaceutical Research and Manufacturers of America says that a whistleblower's False Claims Act lawsuit that contends Merck, Schering-Plough and Millennium marketed Integrilin for off-label uses should be thrown out by a federal court in California. "The prevalence of unapproved but fully legal uses of many FDA-approved prescription medicines to treat patients makes it critical that healthcare professionals have access to accurate, comprehensive, and current information about such uses," the brief reads. Medical Marketing & Media (08/26)


FDA: No proof diet supplements can cure concussions

FDLI SmartBrief | Aug 26, 2014

Lawsuits accuse drugmakers of aggressively marketing painkillers

FDLI SmartBrief | Aug 26, 2014

Save extended access/compassionate use from social media

FDLI SmartBrief | Aug 28, 2014

More cancer meds to be subjected to cost-benefit analyses by NHS England

FDLI SmartBrief | Aug 28, 2014

CMS urged to explain move to withhold data from Open Payments site

FDLI SmartBrief | Aug 27, 2014

Pfizer's C. difficile vaccine wins fast-track status from FDA

FDLI SmartBrief | Aug 29, 2014

Insys' brain-cancer candidate wins orphan status from FDA

FDLI SmartBrief | Aug 26, 2014

FDA urged to do more to add women, minorities to drug trials

FDLI SmartBrief | Aug 27, 2014

FDA approves Iroko's low-dose Zorvolex for osteoarthritis pain

FDLI SmartBrief | Aug 26, 2014


Find FDLI SmartBrief Issues by Date:



FDLI News More >


How transparent are you? -- Brussels, Nov. 13-14

FDLI SmartBrief | Aug 29, 2014

New webinar: Implementation of Pharmaceutical Drug Laws and Regulations by the Food and Drug Administration (FDA), Sept. 24, 1-3 p.m. EDT

FDLI SmartBrief | Aug 29, 2014

30th Anniversary of the Hatch-Waxman Amendments, Sept. 18

FDLI SmartBrief | Aug 28, 2014

Early Bird ends soon!-- Food Advertising Conference, Oct. 8

FDLI SmartBrief | Aug 28, 2014

An FDLI Symposium -- Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Oct. 20

FDLI SmartBrief | Aug 27, 2014




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.